Immediate Impact
26 standout
Citing Papers
Liquid biopsy in cancer: current status, challenges and future prospects
2024 Standout
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial
2024 Standout
Works of Iris Friedli being referenced
Albuminuria‐lowering effect of dapagliflozin, exenatide, and their combination in patients with type 2 diabetes: A randomized cross‐over clinical study
2023
Diffusion-weighted magnetic resonance imaging to assess diffuse renal pathology: a systematic review and statement paper
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Iris Friedli | 348 | 135 | 108 | 13 | 420 | |
| Cindy Blifeld | 102 | 147 | 153 | 12 | 436 | |
| Susanne Tewes | 245 | 195 | 63 | 10 | 389 | |
| Dinah Sherzad Khatir | 114 | 61 | 33 | 19 | 373 | |
| Chad A. Zarse | 87 | 258 | 142 | 10 | 376 | |
| Anni Morsing | 195 | 137 | 28 | 14 | 419 | |
| Soheir Beshara | 30 | 40 | 26 | 15 | 378 | |
| Yaohui Zhang | 85 | 87 | 10 | 21 | 375 | |
| B.O. Helal | 136 | 123 | 82 | 20 | 373 | |
| T. Angusti | 49 | 246 | 29 | 14 | 469 | |
| Sandra Pineda | 72 | 197 | 29 | 20 | 485 |
All Works
Login with ORCID to disown or claim papers
Loading papers...